ArticleInflammatory intestinal diseases

Mayo Endoscopic Subscore at Week 24 Is a Predictor of Future Loss of Response to Vedolizumab in Patients with Ulcerative Colitis in Clinical Remission.

Daisuke Saito et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.